Previous studies demonstrated that GDNF/NTN treatment can inhibit dopaminergic neurons loss and improve deficient behavior in PD model (Oiwa et al., 2002; Liu et al., 2007; Migliore et al., 2014; Tereshchenko et al., 2014). The gene discussed is GDNF; the disease is Parkinson disease.